Difficulty: Medium
Average Score: 68%
Practice
When involved in phase III drug evaluation studies, what responsibilities would the nurse have?
Correct answer
C
Rationale
In phase III studies, nurses monitor patients closely for adverse effects (C) in a large clinical population, collecting data for FDA review, per the text. Animal work (A) occurs in preclinical phases, patient selection (B) is for phase II, and independent research (D) isn't a nurse's role as they don't prescribe, making C the primary responsibility.